The Asia Pacific vaccine market is poised for significant growth in the coming years, driven by several key factors such as the increasing incidence of infectious diseases, advancements in vaccine technologies, and the rising adoption of immunization programs across the region. Valued at USD 4.56 billion in 2023, the market is expected to grow at a compound annual growth rate (CAGR) of 7.8%...